Jiangsu Chuangjian Medical Technology

Trautec is a pioneering company specializing in the re-engineering of gel protein products, targeting high-end markets such as medicine, medical regeneration, and medical beauty. The company operates within the biotechnology sector, focusing on the development and commercialization of recombinant protein materials. Trautec serves a diverse client base, including medical institutions, cosmetic companies, and research organizations. The business model revolves around continuous investment in technological innovation and product research and development, ensuring a robust pipeline of advanced protein-based materials. Revenue is generated through the sale of these specialized protein products and potentially through licensing its proprietary technologies. The company's strategic goal is to lead the global market in re-engineered gel protein products, leveraging its strong technical team and autonomous intellectual property rights.

Keywords: recombinant proteins, biotechnology, medical regeneration, medical beauty, gel proteins, innovation, intellectual property, high-end markets, technological investment, protein materials.